Drugs

All articles by Drugs

Feds try to head off growing problem of overdoses among expectant mothers
Feds try to head off growing problem of overdoses among expectant mothers
Jazmin Orozco Rodriguez, KFF Health News
Katheryn Houghton, KFF Health News
October 23, 2023
9:32 am

Fatal overdoses among pregnant and postpartum people increased by approximately 81% from 2017 to 2020, according to a 2022 study.

Mood-altering mushroom sales bloom despite safety concerns
Mood-altering mushroom sales bloom despite safety concerns
Sam Ogozalek, Tampa Bay Times, KFF Health News
May 31, 2023
11:00 am

Products with mushroom extracts have cropped up at stores and online retailers from Florida to Minnesota and Nebraska to Pennsylvania.

AstraZeneca and Ionis’ ATTRv-PN drug eplontersen shows promise in Phase III study
AstraZeneca and Ionis’ ATTRv-PN drug eplontersen shows promise in Phase III study
Lecia Bushak
April 24, 2023
2:39 pm

Eplontersen, which is being examined for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy, met all of its co-primary endpoints.

Eli Lilly sells Baqsimi to Amphastar for $500M in major diabetes portfolio move
Eli Lilly sells Baqsimi to Amphastar for $500M in major diabetes portfolio move
Jack O'Brien
April 24, 2023
11:14 am

In addition to the $500 million in cash, Amphastar will pay Lilly $125 million in cash upon the one-year anniversary of closing.

Xcopri is making a splash with rainstorm experience at AAN
Xcopri is making a splash with rainstorm experience at AAN
Marc Iskowitz
April 21, 2023
10:00 am

The simulated squall is meant to illustrate Xcopri’s possibility of zero seizures.

Despite pharma claims, illicit drug shipments aren’t full of opioids. It’s generic Viagra.
Despite pharma claims, illicit drug shipments aren’t full of opioids. It’s generic Viagra.
Phil Galewitz, KHN
March 6, 2023
11:30 am

The overwhelming majority were uncontrolled prescription drugs that people had ordered, presumably because they can’t afford the prices at home.

Gilead buys remaining rights to Jounce’s immunotherapy GS-1811
Gilead buys remaining rights to Jounce’s immunotherapy GS-1811
Jack O'Brien
December 28, 2022
11:23 am

Jounce will not be eligible for the remaining contingent payments of up to $645 million in milestones or royalties based upon worldwide sales under the original license agreement.

See which drug price hikes were unsupported by new clinical evidence
See which drug price hikes were unsupported by new clinical evidence
Jack O'Brien
December 7, 2022
1:46 pm

ICER’s list found that seven of the top 10 drugs with net price hikes had “substantial effects” on the U.S. drug spend.

Adderall shortage expands to include Camber, Sun Pharma
Adderall shortage expands to include Camber, Sun Pharma
Jack O'Brien
October 7, 2022
10:32 am

Other pharma companies reporting shortages of the ADHD drug include Amneal, Teva, Par Pharmaceuticals, Rhodes and Sandoz.

Lilly’s COVID drug to go commercial
Lilly’s COVID drug to go commercial
Marc Iskowitz
August 4, 2022
1:00 pm

Bebtelovimab is likely to be the first of the coronavirus vaccines and treatments to make the switch from contract to commercial sales.

  • From Our Partners